AMY WENDELL - Corporate Board Profile

Axogen, Inc.

Filing Date	Source Excerpt
2017-04-07	Amy Wendell, Director (Age 56) Ms. Wendell has served as a member of our Board of Directors since September 2016.
2018-03-29	Amy Wendell, Director (Age 57) Ms. Wendell has served as a member of our Board of Directors since September 2016. She has been a senior advisor for the healthcare investment banking practice of Perella Weinberg Partners (“PWP”) since January 2016. Her scope of responsibilities involves providing guidance and advice with respect to mergers and acquisitions and divestitures for clients, and assisting PWP in connection with firm-level transactions. Since 2015, Ms. Wendell has also been a senior advisor for McKinsey and Company’s (“McKinsey”) strategy and corporate finance practice and also serves as a member of McKinsey’s transactions advisory board to help define trends in mergers and acquisitions, as well as help shape McKinsey’s knowledge agenda. From 1986 until January 2015, Ms. Wendell held various roles of increasing responsibility at Covidien plc (“Covidien”) (including its predecessors, Tyco Healthcare and Kendall Healthcare Products), including in engineering, product management and business development. Most recently, from December 2006 until Covidien’s acquisition by Medtronic plc in January 2015, Ms. Wendell served as Covidien’s Senior Vice President of Strategy and Business Development, where she managed all business development, including acquisitions, equity investments, divestitures and licensing/distribution, and led Covidien’s strategy and portfolio management initiatives. Ms. Wendell is a member of the board of directors of Hologic, Inc. (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products with a strong position in women’s health. She is also a director of Por Cristo, a non-profit charitable medical service organization involved in health care work for at-risk women and children in Latin America. Ms. Wendell holds a Bachelor of Science degree in mechanical engineering from Lawrence Institute of Technology (n/k/a Lawrence Technological University) and a Master of Science degree in biomedical engineering from the University of Illinois. Ms. Wendell’s qualifications to serve on our Board of Directors include her broad healthcare management and governance experience, her knowledge of healthcare policy and regulation, patient care delivery and financing, and her knowledge of clinical research and medical technology assessment.
2019-06-27	Amy Wendell, Director (Age 58) ... Ms. Wendell has served as a member of our Board of Directors since September 2016 and Lead Director since May 2018. ... Messrs. Neels (Chairman) and Rudelius, Ms. Wendell and Dr. Gold are members of the Compensation Committee. Dr. Gold (Chairman) and Messrs. Levine and Neels and Ms. Wendell are members of the Governance and Nominating Committee.
2020-04-17	Messrs. Blackford (Chairman), Levine and Rudelius and Dr. Gold are members of the Audit Committee. Messrs. Neels (Chairman), Blackford and Rudelius, and Ms. Wendell are members of the Compensation Committee. Ms. Wendell (Chairman), Mr. Neels and Dr. Gold are members of the Governance, Nominating and Sustainability Committee.
2021-03-31	Amy Wendell, Director (Age 60) Ms. Wendell has served as a member of our Board of Directors since September 2016 and Lead Director since May 2018. ... Messrs. Neels (Chairman), Blackford and Ms. Wendell are members of the Compensation Committee. ... Ms. Wendell (Chairman) and Messrs. Neels and Thomas are members of the Governance, Nominating and Sustainability Committee. ... The following table sets forth information concerning the compensation of our non-employee directors during the year ended December 31, 2020. ... Amy Wendell 81,000 cash fees, 60,002 stock awards, 60,000 option awards, total 201,002.
2022-04-14	Amy Wendell, Director (Age 61) Ms. Wendell has served as a member of our Board of Directors since September 2016 and Lead Director since May 2018. ... Messrs. Johnson (Chairman), and Levine and Ms. Wendell and Dr. Gold are members of the Audit Committee. ... Ms. Wendell (Chairman) and Messrs. Neels, Johnson and Thomas are members of the Governance, Nominating and Sustainability Committee.
2023-07-07	None
2024-04-24	Amy Wendell has served as a member of our Board of Directors since September 2016 and Lead Director since May 2018. Ms. Wendell is a member of the board of directors of Hologic, Inc., Baxter International, Inc., and Solventum Corp. Ms. Wendell holds a M.S. in biomedical engineering and a B.S. in mechanical engineering.